Article date: August 2000
By: Gillian A Gray, Emma J Mickley, David J Webb, Pauline E McEwan in Volume 130, Issue 8, pages 1735-1744
Endothelin‐1 (ET‐1) has been implicated as a mediator of increased vascular tone during development of heart failure post‐myocardial infarction (MI). In the present study, expression and pharmacology of ET‐1 and its receptors were studied in small mesenteric arteries from rats at 5 and 12 weeks after coronary artery ligation for induction of MI, or sham‐operation.
In vessels from sham‐operated and 5 week post‐MI rats preproET‐1mRNA, immunoreactive (ir) ET‐1, ETB receptor mRNA and irETB receptor were confined to the endothelium, while ETA receptor mRNA was distributed throughout the media. At 12 weeks post‐MI, preproET‐1 and irETA receptor localization was similar but ETB receptor mRNA and immunoreactivity were detectable in the media, as well as the endothelium.
The ET‐1 concentration‐response curve (CRC) was progressively shifted to the right in pressurized third generation mesenteric arteries from 5 and 12 week post‐MI rats relative to sham‐operated rats, with no change in the maximum. The ETA receptor antagonist BQ‐123 (10−6 M) induced a rightward shift of the ET‐1 CRC in all vessels. Desensitization of ETB receptors, by exposure to SRTX S6c (3×10−8 M), had no effect on the ET‐1 CRC in vessels from 5 week post‐MI or sham‐op rats but induced a leftward shift in vessels from 12 week post‐MI rats.
These results identify the endothelium as the primary site of ET‐1 synthesis in small arteries and the ETA receptor as mediating the effects of ET‐1 in these vessels. However, ETB receptor expression increases in vascular smooth muscle post‐MI and is linked to mechanisms that inhibit the contractile response to ET‐1.
Endothelin‐1 (ET‐1) has been implicated as a mediator of increased vascular tone during development of heart failure post‐myocardial infarction (MI). In the present study, expression and pharmacology of ET‐1 and its receptors were studied in small mesenteric arteries from rats at 5 and 12 weeks after coronary artery ligation for induction of MI, or sham‐operation.
In vessels from sham‐operated and 5 week post‐MI rats preproET‐1mRNA, immunoreactive (ir) ET‐1, ETB receptor mRNA and irETB receptor were confined to the endothelium, while ETA receptor mRNA was distributed throughout the media. At 12 weeks post‐MI, preproET‐1 and irETA receptor localization was similar but ETB receptor mRNA and immunoreactivity were detectable in the media, as well as the endothelium.
The ET‐1 concentration‐response curve (CRC) was progressively shifted to the right in pressurized third generation mesenteric arteries from 5 and 12 week post‐MI rats relative to sham‐operated rats, with no change in the maximum. The ETA receptor antagonist BQ‐123 (10−6 M) induced a rightward shift of the ET‐1 CRC in all vessels. Desensitization of ETB receptors, by exposure to SRTX S6c (3×10−8 M), had no effect on the ET‐1 CRC in vessels from 5 week post‐MI or sham‐op rats but induced a leftward shift in vessels from 12 week post‐MI rats.
These results identify the endothelium as the primary site of ET‐1 synthesis in small arteries and the ETA receptor as mediating the effects of ET‐1 in these vessels. However, ETB receptor expression increases in vascular smooth muscle post‐MI and is linked to mechanisms that inhibit the contractile response to ET‐1.
British Journal of Pharmacology (2000) 130, 1735–1744; doi:10.1038/sj.bjp.0703503
DOI: 10.1038/sj.bjp.0703503
View this article